| 000 | 01841 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517202753.0 | ||
| 264 | 0 | _c20180910 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2018.02.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRen, Tong | |
| 245 | 0 | 0 |
_aA novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMay 2018 |
||
| 300 |
_a1-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDiet, High-Fat _xadverse effects |
| 650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aGluconeogenesis _xdrug effects |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aPPAR alpha _xagonists |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 |
_aStreptozocin _xtoxicity |
| 650 | 0 | 4 |
_aSulfonic Acids _xpharmacology |
| 650 | 0 | 4 | _aTranscriptional Activation |
| 700 | 1 | _aYang, Wu-Shuang | |
| 700 | 1 | _aLin, Yi | |
| 700 | 1 | _aLiu, Jin-Feng | |
| 700 | 1 | _aLi, Ying | |
| 700 | 1 | _aYang, Li-Chao | |
| 700 | 1 | _aZeng, Kai-Yue | |
| 700 | 1 | _aPeng, Lu | |
| 700 | 1 | _aLiu, Yi-Jun | |
| 700 | 1 | _aYe, Zhen-Hong | |
| 700 | 1 | _aLuo, Xiu-Mei | |
| 700 | 1 | _aKe, Yu-Jie | |
| 700 | 1 | _aDiao, Yong | |
| 700 | 1 | _aJin, Xin | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 826 _gp. 1-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2018.02.029 _zAvailable from publisher's website |
| 999 |
_c28118602 _d28118602 |
||